AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 4%

AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 4%




AbbVie’s earnings topped estimates as it offered an upbeat view of 2025.



Source link

Tagged:

Related News

Popular News

Categories Collection

Recent News